Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815–820
Gopal VD, Rabkin JM, Brian SB, Corless CL, Chou S, Olyaei A, Orloff SL, Rosen HR (2001) Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin. Liver Transpl 7: 181–190
Manns PM, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodmann ZD, Koury K, Ling MH, Albrecht JK (2001) Peginterferon alpha 2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis c: a randomised trial. Lancet 358: 958–965
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goneales FL, Häussinger D, Oiago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alpha-2a plus ribavirin for chronic hepatitis c virus infection. N Engl J Med 347: 975–982
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bahra, M., Neumann, U.P., Berg, T., Neuhaus, R., Langrehr, J.M., Neuhaus, P. (2003). Verbesserung der virologischen Ansprechrate durch Therapie mit pegyliertem Interferon alpha-2-b plus Ribavirin nach Lebertransplantation bei Hepatitis-C-Zirrhose. In: Menger, M.D., Haas, N.P., Neugebauer, E., Bauer, H. (eds) Chirurgisches Forum 2003 für experimentelle und klinische Forschung. Deutsche Gesellschaft für Chirurgie, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19024-7_95
Download citation
DOI: https://doi.org/10.1007/978-3-642-19024-7_95
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00659-6
Online ISBN: 978-3-642-19024-7
eBook Packages: Springer Book Archive